FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
admin 19th April 2017 Uncategorised 0 FDA document lays out issues undermining approval of AstraZeneca’s ZS Pharma drug
epalmer
Wed, 04/19/2017 – 15:34
More: FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Source: fierce